Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000805701 | SCV000945667 | likely benign | Achondrogenesis, type IB; Atelosteogenesis type II; Multiple epiphyseal dysplasia type 4; Diastrophic dysplasia | 2025-01-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003166250 | SCV003871620 | uncertain significance | Inborn genetic diseases | 2023-02-06 | criteria provided, single submitter | clinical testing | The c.1234G>A (p.V412I) alteration is located in exon 3 (coding exon 2) of the SLC26A2 gene. This alteration results from a G to A substitution at nucleotide position 1234, causing the valine (V) at amino acid position 412 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |